Table 1.
Clinical and demographic characteristics of the patients
| Variable | All patients (N = 35) |
|---|---|
| Age (years), median (range) | 66 (20–93) |
| Gender (males) | 25 (71%) |
| Reasons for hospitalization | |
| Pulmonary COVID-19 | 19 (54%) |
| Neurological symptoms | 14 (43%) |
| No admission (outpatient consultation) | 2 (3%) |
| Severity of illness | |
| Severe (moderate to high risk) pneumonia (CURB-65 2-5) | 13 (37%) |
| Mild (low risk) pneumonia (CURB-65 0-1) | 18 (51%) |
| Mild infection without pneumonia | 4 |
| Cardiovascular risk factors | 26 (74%) |
| Hypertension | 20 (57%) |
| Hyperlipidemia | 14 (60%) |
| Diabetes mellitus | 6 (17%) |
| Smoking | 8 (23%) |
| Overweight (BMI ≥30) | 2 (6%) |
| Cardiovascular comorbidities (AF, ischemic cardiopathy) | 9 (26%) |
| Pulmonary comorbidities (COPD, asthma, OSAS) | 8 (23%) |
| Neurological comorbidities | 14 (40%) |
| Cognitive impairment | 2 |
| Migraine | 3 |
| Epilepsy | 2 |
| Stroke or TIA | 3 |
| Spinal stenosis | 2 |
| Parkinson’s disease | 1 |
| Normal pressure hydrocephalus | 1 |
AF atrial fibrillation, BMI body mass index, COPD chronic obstructive pulmonary disease, OSAS obstructive sleep apnea syndrome, TIA transient ischemic attack